Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2017 | 1 |
2020 | 1 |
2021 | 1 |
2022 | 1 |
2023 | 3 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Metastatic pheochromocytomas and paragangliomas: where are we?
Tumori. 2022 Dec;108(6):526-540. doi: 10.1177/03008916221078621. Epub 2022 May 20.
Tumori. 2022.
PMID: 35593402
Review.
Neutralizing antibodies to Omicron after the fourth SARS-CoV-2 mRNA vaccine dose in immunocompromised patients highlight the need of additional boosters.
Rescigno M, Agrati C, Salvarani C, Giannarelli D, Costantini M, Mantovani A, Massafra R, Zinzani PL, Morrone A, Notari S, Matusali G, Pinter GL, Uccelli A, Ciliberto G, Baldanti F, Locatelli F, Silvestris N, Sinno V, Turola E, Lupo-Stanghellini MT, Apolone G; VAX4FRAIL study Group.
Rescigno M, et al.
Front Immunol. 2023 Jan 27;14:1104124. doi: 10.3389/fimmu.2023.1104124. eCollection 2023.
Front Immunol. 2023.
PMID: 36776853
Free PMC article.
Item in Clipboard
Humoral and T-Cell Immune Response After 3 Doses of Messenger RNA Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines in Fragile Patients: The Italian VAX4FRAIL Study.
Corradini P, Agrati C, Apolone G, Mantovani A, Giannarelli D, Marasco V, Bordoni V, Sacchi A, Matusali G, Salvarani C, Zinzani PL, Mantegazza R, Tagliavini F, Lupo-Stanghellini MT, Ciceri F, Damian S, Uccelli A, Fenoglio D, Silvestris N, Baldanti F, Piaggio G, Ciliberto G, Morrone A, Locatelli F, Sinno V, Rescigno M, Costantini M; VAX4FRAIL Study Group.
Corradini P, et al.
Clin Infect Dis. 2023 Feb 8;76(3):e426-e438. doi: 10.1093/cid/ciac404.
Clin Infect Dis. 2023.
PMID: 35607769
Free PMC article.
Item in Clipboard
Assessing the safety and activity of cabozantinib combined with lanreotide in gastroenteropancreatic and thoracic neuroendocrine tumors: rationale and protocol of the phase II LOLA trial.
Corti F, Brizzi MP, Amoroso V, Giuffrida D, Panzuto F, Campana D, Prinzi N, Milione M, Cascella T, Spreafico C, Randon G, Oldani S, Leporati R, Scotto G, Pulice I, Stocchetti BL, Porcu L, Coppa J, Di Bartolomeo M, de Braud F, Pusceddu S.
Corti F, et al. Among authors: pulice i.
BMC Cancer. 2023 Sep 26;23(1):908. doi: 10.1186/s12885-023-11287-2.
BMC Cancer. 2023.
PMID: 37752423
Free PMC article.
Item in Clipboard
Target therapies plus somatostatin analogs in NETs: a network meta-analysis.
Pusceddu S, Facciorusso A, Giacomelli L, Prinzi N, Corti F, Niger M, Milione M, Coppa J, Cascella T, Pulice I, Biamonte L, Papa S, Di Bartolomeo M, Shah A, Sacco R, de Braud F.
Pusceddu S, et al. Among authors: pulice i.
Endocr Relat Cancer. 2021 Jun 17;28(7):467-479. doi: 10.1530/ERC-20-0492.
Endocr Relat Cancer. 2021.
PMID: 33979777
Item in Clipboard
Rationale and protocol of MetNET-2 trial: Lanreotide Autogel plus metformin in advanced gastrointestinal or lung neuroendocrine tumors.
Pusceddu S, Prinzi N, Lo Russo G, Femia D, Milione M, Perrone F, Tamborini E, Concas L, Pulice I, Vernieri C, Corti F, Buzzoni R, de Braud F.
Pusceddu S, et al. Among authors: pulice i.
Future Oncol. 2017 Aug;13(19):1677-1683. doi: 10.2217/fon-2017-0132. Epub 2017 Jun 5.
Future Oncol. 2017.
PMID: 28580793
Free article.
Item in Clipboard
Red clover and lifestyle changes to contrast menopausal symptoms in premenopausal patients with hormone-sensitive breast cancer receiving tamoxifen.
Ferraris C, Ballestra B, Listorti C, Cappelletti V, Reduzzi C, Scaperrotta GP, Pulice I, Ferrari EGA, Folli S, Mariani L, Martelli G.
Ferraris C, et al. Among authors: pulice i.
Breast Cancer Res Treat. 2020 Feb;180(1):157-165. doi: 10.1007/s10549-020-05534-4. Epub 2020 Jan 24.
Breast Cancer Res Treat. 2020.
PMID: 31975316
Item in Clipboard
Cite
Cite